Fast and Secure Delivery Worldwide Express & Expedited Shipping Service
USD $359.38
IndiaOlabir (Olaparib) is a medication primarily used for the treatment of certain types of cancer, particularly those associated with BRCA gene mutations. It belongs to a class of drugs known as PARP inhibitors, which work by interfering with the cancer cell's ability to repair its DNA, ultimately leading to cell death.
Olaparib targets cancer cells with defective DNA repair mechanisms, specifically those with mutations in the BRCA1 and BRCA2 genes. By inhibiting the enzyme PARP, it prevents cancer cells from repairing their DNA, resulting in increased cancer cell death.
Olabir is indicated for patients with ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer who have specific genetic mutations. It is often used after prior chemotherapy treatments.
The recommended dosage of Olabir varies based on the type of cancer and the patient's overall health. It is typically administered orally in tablet form and should be taken as prescribed by a healthcare provider.
Common side effects of Olabir may include nausea, fatigue, anemia, and decreased appetite. Patients should report any severe or persistent side effects to their healthcare provider immediately.
Before starting Olabir, patients should inform their healthcare provider of any existing medical conditions, allergies, or medications they are currently taking. Regular monitoring may be required during treatment.
Olabir (Olaparib) represents a significant advancement in targeted cancer therapy, offering hope to patients with specific genetic mutations. Always consult with a healthcare professional for personalized medical advice and treatment options.
